Major adverse cardiac events in symptomatic women with non-obstructive CAD on coronary CTA: pooled analysis from PROMISE and SCOT-HEART.

Journal Article (Journal Article)

The presence of non-obstructive coronary artery disease (CAD) on coronary computed tomography angiography (CTA) has been associated with the occurrence of major adverse cardiac events (MACE). However, factors associated with the development of MACE in symptomatic women with non-obstructive CAD on coronary CTA have not been fully elucidated. We sought to examine the influence of risk factors and coronary artery calcification on MACE in symptomatic women with non-obstructive CAD on coronary CTA. Women from PROMISE and SCOT-HEART trials with none or non-obstructive CAD on coronary CTA comprised the study cohort. Baseline characteristics and clinical presentation were assessed. Survival analysis using Kaplan-Meier curves was done to compare outcomes stratified by the atherosclerotic cardiovascular disease (ASCVD) risk score and the Agatston score. The primary endpoint was a composite of all-cause mortality, myocardial infarction, and revascularization. 2597 women had non-obstructive CAD or normal coronary CTA, with a median follow-up of 32 months. Compared to women without MACE, women with MACE had lower high-density lipoprotein cholesterol (HDL-C) levels and higher mean ASCVD risk scores. Further, women with non-obstructive CAD and ASCVD ≥ 7.5% had higher risk of MACE than those with ASCVD < 7.5% [3.2% vs. 1.1%, adjusted HR (aHR) of 3.1 (95% CI 1.32, 7.23), P-value 0.009]. The Agatston calcium score, on the other hand, was not independently associated with MACE among this population of symptomatic women. Symptomatic women with non-obstructive CAD on coronary CTA are at higher risk for MACE, with the ASCVD risk score being independently associated with the occurrence of adverse events.

Full Text

Duke Authors

Cited Authors

  • Mansour, M; Radaideh, Q; Alaiwah, MN; Alnimer, Y; Devabhaktuni, SR; Dhar, G; Vallurupalli, S; Michos, ED; Newby, DE; Williams, MC; Fudim, M; Al'Aref, SJ

Published Date

  • March 2022

Published In

Volume / Issue

  • 38 / 3

Start / End Page

  • 683 - 693

PubMed ID

  • 34628593

Pubmed Central ID

  • PMC8930619

Electronic International Standard Serial Number (EISSN)

  • 1875-8312

Digital Object Identifier (DOI)

  • 10.1007/s10554-021-02429-3


  • eng

Conference Location

  • United States